Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Animal models is known as those animals on which pathological and biological experiments are performed and tested. Animal models are implemented as animal and human beings share important physiological & organic structure. Moreover, some of the animals species have related genetic structure to the humans. Hence, animal models are utilized by scientists and researcher to study and find cure for diseases, test the final medicinal drugs before it is used on humans and also for development of new products. Novel drugs are examined in animals for their safety and efficacy prior examination in humans.
The North America animal model market is witnessing lucrative growth during the forecast period of 2021 to 2027. The animal model is used for drug discovery and development, basic research and others. The dynamic factors such as rising demand for use of animal models to perform various studies is propelling growth of North America animal model market. Rising importance of genetics in biomedical studies is also boosting growth of North America animal model market. However, regulation and laws for ethical use of animals is restraining growth of North America animal model market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the animal model market. In addition, complete analysis of changes on animal model expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on North America economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The rising incidences of various diseases and viral infections such as COVID-19 increases the demand for animal models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of animal model market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of animal model market during COVID-19 period.
The North America animal market is bifurcated into animal type, application, end user and country.
Animal type such as pigs, cats, mice, monkey, rabbit and other animal such as dog in the North America animal model market. In which rabbit is also contributing to the growth of North America animal model market. The rabbit model provides a straightforward and relevant method for assessing post-immunization protection against infections. The rabbit models provides the several advantages like high-affinity antigen-specific antibody responses to almost any type of antigen and very low non-specific responses.
Application such as research and development and production and quality control are comprised in the North America animal model market. The production and quality control is also contributing to the growth of North America animal model market. The rising research and development activities is propelling growth of North America animal model market. The growing production of new medicines is also boosting growth of North America animal model market.
End user such as research institutes, pharmaceutical companies, contract research organizations and educational institutes. In which pharmaceutical companies is also contributing to the growth of North America animal model market. The rising product launches is propelling growth of North America animal model market. The growing exigency for safety testing of medicines is also boosting growth of North America animal model market.
The key players comprised in animal model market are Janvier Labs, Charles River Laboratories, Genoway S.A., Envigo, Taconic Laboratories, Transgenic Inc., Sage Labs, Horizon Discovery, Crown Bioscience Inc. and Harbor Antibodies Bv (A Subsidiary Of Harbor Biomed) among others.
Apr 2021: Horizon Discovery is shared that IGM Biosciences, a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies has signed a multi-license commercial agreement within two years of their first license for the continued use of the Horizons cGMP-compliant CHO SOURCE platform for further development of IGM’s novel therapeutic IgM antibodies.
January 2020: Horizon Discovery Group plc (Horizon or the Group), a global leader in the application of gene editing and gene modulation technologies, has announced the collaboration and license agreement with Mammoth Biosciences (Mammoth or the Company), for access of Mammoth’s novel CRISPR platform and thereby facilitate delivery of a new generation of genetically engineered CHO cells for the production of biotherapeutics such as therapeutic antibodies.
December 2019: Horizon Discovery Group plc (Horizon), a global leader in the application of gene editing and gene modulation for cell line engineering, announced their partnership with The Human Protein Atlas (HPA). HPA has selected Horizon’s CRISPR-edited knockout cell models to further expand the knowledge available in its Cell Atlas program, to advance our understanding of the genetic drivers of disease.
September 2019: Horizon Discovery Group plc (Horizon), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the full commercial licensing to Glen Mark Pharmaceuticals, a global innovative pharmaceutical company, for its gene-edited Glutamine Synthetizes (GS) knockout Chinese Hamster Ovary (CHO) K1 cell line. Terms of the agreement were based on stringent evaluation of the cell line by Glen mark to assess its suitability for adoption into the Company’s biomanufacturing processes.
March 2019: Horizon Discovery Group plc (Horizon), a global leader in gene editing and gene modulation technologies, announced their collaboration with St George’s University Hospital, London, and the European Molecular Genetics Quality Network (EMQN), based within the Manchester Centre for Genomic Medicine at Saint Mary’s Hospital, to develop reference material for non-invasive prenatal testing (NIPT).
The report analyses the animal model market based on animal type, application, end user and country. The various types of animals covered in the report are pigs, cats, mice, monkey, rabbit and other animal such as dog. By application, the market is segmented into research and development and production and quality control. Based on end user, the market is segmented into research institutes, pharmaceutical companies, contract research organizations and educational institutes. The report also covered the impact of COVID-19 on the animal model market and it is found that the rising incidences of various diseases and viral infections such as COVID-19 increases the demand for animal models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of animal model market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of animal model market during COVID-19 period. The report also covers the major key players operating in the market.
Why to buy this report
